Rigel Pharmaceuticals reported $43M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acura Pharmaceuticals ACUR:US 913K 123K
Agenus AGEN:US $ 61.4M 12.89M
Amgen AMGN:US $ 3.74B 804M
Anika Therapeutics ANIK:US $ 40.25M 4.7M
Applied Genetic Technologies AGTC:US $ 13.58M 4.86M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Astrazeneca AZN:US 10.51B 1.79B
AstraZeneca AZN:LN 10.51B 1.79B
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Celldex Therapeutics CLDX:US $ 23.43M 2.76M
Chemocentryx CCXI:US $ 43.69M 1.33M
Daiichi Sankyo 4568:JP 284.67B 42.7B
Eli Lilly And LLY:US $ 5405.7M 677M
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Immunogen IMGN:US $ 60.93M 1.62M
Intrexon XON:US $ 49.92M 5.21M
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Macrogenics MGNX:US $ 77.74M 5.36M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Pfizer PFE:US $ 15788M 3271M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Rigel Pharmaceuticals RIGL:US $ 43M 1.17M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Veracyte VCYT:US $ 83.03M 3.36M